//
Yan Hou
Xi Lei
Benjamin Li
Jie Shen
Hui Zhou
Yiming Wang
Alexandra H. Marshall
Heyu Ni
Xiangrong Dai
Zhongqiang Yang
Fang Qian
Guohui Zhang
Zhengyu Xu
Jing Liu
Chaofan Liang
Yanan Zhao
Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, Toronto Platelet Immunobiology Group, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
Keenan Research Center, Li Ka Shing Knowledge Institute, St. Michaels Hospital, Department of Laboratory Medicine and Pathobiology, and Toronto Platelet Immunobiology Group, University of Toronto, Toronto, ON, Canada
St. Michaels Hospital
School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui, China
Gejishan Hospital of Wannan Medical College, Wuhu, China
Department of Laboratory Medicine, Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital
Toronto Platelet Immunobiology Group, Toronto, ON, Canada
Canadian Blood Services, Toronto, ON, Canada
Canada
China
Zhaoke Pharmaceutica
Lee's Pharmaceutical
Obstetrics/Gynecology
Venous thrombosis
Twin-reversed arterial perfusion
Triiodothyronine receptor auxiliary protein
von Willebrand factor
Activated partial thromboplastin time
Anfibatide
Fibrinogen (IV)
Hemostatic Solution
Evithrom
N/A
N/A
I
N/A
N/A
Interim